nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—multiple sclerosis	0.126	0.266	CbGbCtD
Perphenazine—CYP2D6—Fingolimod—multiple sclerosis	0.0597	0.126	CbGbCtD
Perphenazine—CYP3A4—Fingolimod—multiple sclerosis	0.0379	0.0802	CbGbCtD
Perphenazine—CYP2C19—Prednisone—multiple sclerosis	0.0306	0.0648	CbGbCtD
Perphenazine—CYP2B6—Dexamethasone—multiple sclerosis	0.0301	0.0636	CbGbCtD
Perphenazine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0245	0.0517	CbGbCtD
Perphenazine—CYP2C8—Dexamethasone—multiple sclerosis	0.0228	0.0482	CbGbCtD
Perphenazine—CYP2C19—Dexamethasone—multiple sclerosis	0.0191	0.0404	CbGbCtD
Perphenazine—CYP3A4—Triamcinolone—multiple sclerosis	0.0185	0.0392	CbGbCtD
Perphenazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0183	0.112	CbGeAlD
Perphenazine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0178	0.0377	CbGbCtD
Perphenazine—CYP2C9—Dexamethasone—multiple sclerosis	0.0159	0.0336	CbGbCtD
Perphenazine—CYP3A4—Betamethasone—multiple sclerosis	0.0159	0.0336	CbGbCtD
Perphenazine—CYP3A4—Prednisolone—multiple sclerosis	0.0157	0.0331	CbGbCtD
Perphenazine—CYP3A4—Prednisone—multiple sclerosis	0.0148	0.0313	CbGbCtD
Perphenazine—CYP2D6—Dexamethasone—multiple sclerosis	0.0145	0.0307	CbGbCtD
Perphenazine—CYP3A4—Dexamethasone—multiple sclerosis	0.00925	0.0195	CbGbCtD
Perphenazine—CALM1—trigeminal nerve—multiple sclerosis	0.00787	0.0484	CbGeAlD
Perphenazine—CALM2—pons—multiple sclerosis	0.00557	0.0342	CbGeAlD
Perphenazine—CALM1—pons—multiple sclerosis	0.00554	0.0341	CbGeAlD
Perphenazine—HTR7—pons—multiple sclerosis	0.00541	0.0333	CbGeAlD
Perphenazine—HTR2A—trigeminal nerve—multiple sclerosis	0.0048	0.0295	CbGeAlD
Perphenazine—DRD1—nerve—multiple sclerosis	0.00449	0.0276	CbGeAlD
Perphenazine—CALM2—pineal body—multiple sclerosis	0.00397	0.0244	CbGeAlD
Perphenazine—CALM1—pineal body—multiple sclerosis	0.00396	0.0243	CbGeAlD
Perphenazine—CALM2—peripheral nervous system—multiple sclerosis	0.0037	0.0228	CbGeAlD
Perphenazine—CALM1—peripheral nervous system—multiple sclerosis	0.00369	0.0227	CbGeAlD
Perphenazine—HTR7—peripheral nervous system—multiple sclerosis	0.0036	0.0221	CbGeAlD
Perphenazine—HTR2A—pons—multiple sclerosis	0.00338	0.0208	CbGeAlD
Perphenazine—CALM2—nerve—multiple sclerosis	0.00289	0.0178	CbGeAlD
Perphenazine—CALM1—nerve—multiple sclerosis	0.00287	0.0177	CbGeAlD
Perphenazine—HTR7—nerve—multiple sclerosis	0.00281	0.0173	CbGeAlD
Perphenazine—DRD2—nerve—multiple sclerosis	0.00266	0.0163	CbGeAlD
Perphenazine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00264	0.0162	CbGeAlD
Perphenazine—HTR2A—pineal body—multiple sclerosis	0.00241	0.0148	CbGeAlD
Perphenazine—HTR2A—peripheral nervous system—multiple sclerosis	0.00225	0.0138	CbGeAlD
Perphenazine—DRD1—brainstem—multiple sclerosis	0.00193	0.0119	CbGeAlD
Perphenazine—HTR2A—nerve—multiple sclerosis	0.00175	0.0108	CbGeAlD
Perphenazine—CALM3—retina—multiple sclerosis	0.00152	0.00937	CbGeAlD
Perphenazine—HTR2C—brainstem—multiple sclerosis	0.0015	0.00922	CbGeAlD
Perphenazine—HTR6—nervous system—multiple sclerosis	0.00136	0.00835	CbGeAlD
Perphenazine—HTR6—central nervous system—multiple sclerosis	0.00131	0.00804	CbGeAlD
Perphenazine—HTR1A—brainstem—multiple sclerosis	0.00126	0.00776	CbGeAlD
Perphenazine—CALM2—brainstem—multiple sclerosis	0.00124	0.00762	CbGeAlD
Perphenazine—CALM1—brainstem—multiple sclerosis	0.00123	0.00759	CbGeAlD
Perphenazine—DRD1—midbrain—multiple sclerosis	0.00123	0.00756	CbGeAlD
Perphenazine—HTR7—brainstem—multiple sclerosis	0.00121	0.00741	CbGeAlD
Perphenazine—CALM2—retina—multiple sclerosis	0.0012	0.00735	CbGeAlD
Perphenazine—CALM1—retina—multiple sclerosis	0.00119	0.00732	CbGeAlD
Perphenazine—DRD2—brainstem—multiple sclerosis	0.00114	0.00701	CbGeAlD
Perphenazine—CALM3—medulla oblongata—multiple sclerosis	0.0011	0.00677	CbGeAlD
Perphenazine—DRD2—retina—multiple sclerosis	0.0011	0.00676	CbGeAlD
Perphenazine—HTR2C—medulla oblongata—multiple sclerosis	0.00104	0.00643	CbGeAlD
Perphenazine—HTR6—brain—multiple sclerosis	0.00104	0.00639	CbGeAlD
Perphenazine—DRD1—nervous system—multiple sclerosis	0.00101	0.00622	CbGeAlD
Perphenazine—CALM3—midbrain—multiple sclerosis	0.00101	0.00619	CbGeAlD
Perphenazine—CALM3—spinal cord—multiple sclerosis	0.000982	0.00604	CbGeAlD
Perphenazine—DRD1—central nervous system—multiple sclerosis	0.000973	0.00598	CbGeAlD
Perphenazine—HTR2C—midbrain—multiple sclerosis	0.000955	0.00587	CbGeAlD
Perphenazine—HTR2C—spinal cord—multiple sclerosis	0.000932	0.00573	CbGeAlD
Perphenazine—CALM2—medulla oblongata—multiple sclerosis	0.000864	0.00532	CbGeAlD
Perphenazine—AOX1—cerebellum—multiple sclerosis	0.000864	0.00531	CbGeAlD
Perphenazine—CALM1—medulla oblongata—multiple sclerosis	0.00086	0.00529	CbGeAlD
Perphenazine—HTR7—medulla oblongata—multiple sclerosis	0.000841	0.00517	CbGeAlD
Perphenazine—HTR1A—midbrain—multiple sclerosis	0.000804	0.00494	CbGeAlD
Perphenazine—CALM2—midbrain—multiple sclerosis	0.00079	0.00486	CbGeAlD
Perphenazine—CALM1—midbrain—multiple sclerosis	0.000786	0.00484	CbGeAlD
Perphenazine—HTR2C—nervous system—multiple sclerosis	0.000785	0.00483	CbGeAlD
Perphenazine—HTR1A—spinal cord—multiple sclerosis	0.000784	0.00482	CbGeAlD
Perphenazine—CALM3—cerebellum—multiple sclerosis	0.000778	0.00479	CbGeAlD
Perphenazine—DRD1—brain—multiple sclerosis	0.000773	0.00475	CbGeAlD
Perphenazine—CALM2—spinal cord—multiple sclerosis	0.000771	0.00474	CbGeAlD
Perphenazine—HTR7—midbrain—multiple sclerosis	0.000768	0.00472	CbGeAlD
Perphenazine—CALM1—spinal cord—multiple sclerosis	0.000767	0.00472	CbGeAlD
Perphenazine—HTR2C—central nervous system—multiple sclerosis	0.000756	0.00465	CbGeAlD
Perphenazine—HTR2A—brainstem—multiple sclerosis	0.000752	0.00462	CbGeAlD
Perphenazine—HTR7—spinal cord—multiple sclerosis	0.00075	0.00461	CbGeAlD
Perphenazine—DRD2—midbrain—multiple sclerosis	0.000726	0.00447	CbGeAlD
Perphenazine—HTR2A—retina—multiple sclerosis	0.000725	0.00446	CbGeAlD
Perphenazine—AOX1—brain—multiple sclerosis	0.000702	0.00432	CbGeAlD
Perphenazine—CYP2D6—brainstem—multiple sclerosis	0.000685	0.00421	CbGeAlD
Perphenazine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000673	0.00429	CcSEcCtD
Perphenazine—HTR1A—nervous system—multiple sclerosis	0.000661	0.00406	CbGeAlD
Perphenazine—Headache—Fingolimod—multiple sclerosis	0.000656	0.00418	CcSEcCtD
Perphenazine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000651	0.00415	CcSEcCtD
Perphenazine—CALM2—nervous system—multiple sclerosis	0.00065	0.00399	CbGeAlD
Perphenazine—CALM1—nervous system—multiple sclerosis	0.000647	0.00398	CbGeAlD
Perphenazine—HTR1A—central nervous system—multiple sclerosis	0.000636	0.00391	CbGeAlD
Perphenazine—Cough—Cladribine—multiple sclerosis	0.000634	0.00405	CcSEcCtD
Perphenazine—CALM3—brain—multiple sclerosis	0.000632	0.00389	CbGeAlD
Perphenazine—HTR7—nervous system—multiple sclerosis	0.000632	0.00388	CbGeAlD
Perphenazine—CALM2—central nervous system—multiple sclerosis	0.000625	0.00385	CbGeAlD
Perphenazine—CALM1—central nervous system—multiple sclerosis	0.000622	0.00383	CbGeAlD
Perphenazine—HTR1A—cerebellum—multiple sclerosis	0.000622	0.00382	CbGeAlD
Perphenazine—Cardiac arrest—Prednisolone—multiple sclerosis	0.000619	0.00395	CcSEcCtD
Perphenazine—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000619	0.00395	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000619	0.00394	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000617	0.00394	CcSEcCtD
Perphenazine—ADRA2A—medulla oblongata—multiple sclerosis	0.000617	0.00379	CbGeAlD
Perphenazine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000612	0.0039	CcSEcCtD
Perphenazine—CALM2—cerebellum—multiple sclerosis	0.000611	0.00376	CbGeAlD
Perphenazine—CALM1—cerebellum—multiple sclerosis	0.000608	0.00374	CbGeAlD
Perphenazine—HTR7—central nervous system—multiple sclerosis	0.000608	0.00374	CbGeAlD
Perphenazine—HTR2C—brain—multiple sclerosis	0.0006	0.00369	CbGeAlD
Perphenazine—Confusional state—Cladribine—multiple sclerosis	0.000598	0.00382	CcSEcCtD
Perphenazine—DRD2—nervous system—multiple sclerosis	0.000597	0.00367	CbGeAlD
Perphenazine—Jaundice—Mitoxantrone—multiple sclerosis	0.000596	0.0038	CcSEcCtD
Perphenazine—HTR7—cerebellum—multiple sclerosis	0.000594	0.00365	CbGeAlD
Perphenazine—Infection—Cladribine—multiple sclerosis	0.00059	0.00376	CcSEcCtD
Perphenazine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000583	0.00372	CcSEcCtD
Perphenazine—Tachycardia—Cladribine—multiple sclerosis	0.000579	0.00369	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—multiple sclerosis	0.000576	0.00367	CcSEcCtD
Perphenazine—DRD2—central nervous system—multiple sclerosis	0.000575	0.00354	CbGeAlD
Perphenazine—Muscular weakness—Prednisolone—multiple sclerosis	0.000574	0.00366	CcSEcCtD
Perphenazine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000571	0.00364	CcSEcCtD
Perphenazine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.000569	0.00363	CcSEcCtD
Perphenazine—Hyperkinesia—Prednisone—multiple sclerosis	0.000568	0.00362	CcSEcCtD
Perphenazine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.000568	0.00362	CcSEcCtD
Perphenazine—Anorexia—Cladribine—multiple sclerosis	0.000566	0.00361	CcSEcCtD
Perphenazine—ADRA2A—midbrain—multiple sclerosis	0.000563	0.00346	CbGeAlD
Perphenazine—DRD2—cerebellum—multiple sclerosis	0.000562	0.00346	CbGeAlD
Perphenazine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000561	0.00358	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000561	0.00358	CcSEcCtD
Perphenazine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000559	0.00356	CcSEcCtD
Perphenazine—Hypotension—Cladribine—multiple sclerosis	0.000554	0.00354	CcSEcCtD
Perphenazine—Lethargy—Betamethasone—multiple sclerosis	0.000554	0.00353	CcSEcCtD
Perphenazine—Lethargy—Dexamethasone—multiple sclerosis	0.000554	0.00353	CcSEcCtD
Perphenazine—Ethopropazine—BCHE—multiple sclerosis	0.00055	0.261	CrCbGaD
Perphenazine—ADRA2A—spinal cord—multiple sclerosis	0.00055	0.00338	CbGeAlD
Perphenazine—Insomnia—Cladribine—multiple sclerosis	0.000537	0.00342	CcSEcCtD
Perphenazine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000531	0.00338	CcSEcCtD
Perphenazine—Psychotic disorder—Betamethasone—multiple sclerosis	0.000531	0.00338	CcSEcCtD
Perphenazine—Leukopenia—Azathioprine—multiple sclerosis	0.000529	0.00337	CcSEcCtD
Perphenazine—Dyspnoea—Cladribine—multiple sclerosis	0.000529	0.00337	CcSEcCtD
Perphenazine—Muscular weakness—Triamcinolone—multiple sclerosis	0.000528	0.00337	CcSEcCtD
Perphenazine—Somnolence—Cladribine—multiple sclerosis	0.000528	0.00336	CcSEcCtD
Perphenazine—Muscular weakness—Methylprednisolone—multiple sclerosis	0.000527	0.00336	CcSEcCtD
Perphenazine—HTR2A—medulla oblongata—multiple sclerosis	0.000524	0.00322	CbGeAlD
Perphenazine—Asthma—Triamcinolone—multiple sclerosis	0.000517	0.0033	CcSEcCtD
Perphenazine—Cardiac arrest—Betamethasone—multiple sclerosis	0.000517	0.00329	CcSEcCtD
Perphenazine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000517	0.00329	CcSEcCtD
Perphenazine—Decreased appetite—Cladribine—multiple sclerosis	0.000516	0.00329	CcSEcCtD
Perphenazine—Pain—Cladribine—multiple sclerosis	0.000507	0.00324	CcSEcCtD
Perphenazine—Constipation—Cladribine—multiple sclerosis	0.000507	0.00324	CcSEcCtD
Perphenazine—HTR1A—brain—multiple sclerosis	0.000505	0.00311	CbGeAlD
Perphenazine—CALM2—brain—multiple sclerosis	0.000496	0.00305	CbGeAlD
Perphenazine—CALM1—brain—multiple sclerosis	0.000494	0.00304	CbGeAlD
Perphenazine—Urine output increased—Methotrexate—multiple sclerosis	0.000492	0.00314	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—multiple sclerosis	0.000487	0.00311	CcSEcCtD
Perphenazine—CYP2B6—nervous system—multiple sclerosis	0.000483	0.00297	CbGeAlD
Perphenazine—Lethargy—Prednisone—multiple sclerosis	0.000483	0.00308	CcSEcCtD
Perphenazine—HTR7—brain—multiple sclerosis	0.000483	0.00297	CbGeAlD
Perphenazine—Infection—Azathioprine—multiple sclerosis	0.000479	0.00306	CcSEcCtD
Perphenazine—Muscular weakness—Betamethasone—multiple sclerosis	0.000479	0.00306	CcSEcCtD
Perphenazine—Muscular weakness—Dexamethasone—multiple sclerosis	0.000479	0.00306	CcSEcCtD
Perphenazine—HTR2A—midbrain—multiple sclerosis	0.000479	0.00295	CbGeAlD
Perphenazine—Erythema—Mitoxantrone—multiple sclerosis	0.000478	0.00305	CcSEcCtD
Perphenazine—HRH1—nervous system—multiple sclerosis	0.000472	0.0029	CbGeAlD
Perphenazine—Urticaria—Cladribine—multiple sclerosis	0.000471	0.00301	CcSEcCtD
Perphenazine—Body temperature increased—Cladribine—multiple sclerosis	0.000469	0.00299	CcSEcCtD
Perphenazine—HTR2A—spinal cord—multiple sclerosis	0.000467	0.00287	CbGeAlD
Perphenazine—CYP2B6—central nervous system—multiple sclerosis	0.000465	0.00286	CbGeAlD
Perphenazine—ADRA2A—nervous system—multiple sclerosis	0.000463	0.00285	CbGeAlD
Perphenazine—Psychotic disorder—Prednisone—multiple sclerosis	0.000462	0.00295	CcSEcCtD
Perphenazine—Bradycardia—Prednisolone—multiple sclerosis	0.000459	0.00292	CcSEcCtD
Perphenazine—DRD2—brain—multiple sclerosis	0.000456	0.00281	CbGeAlD
Perphenazine—HRH1—central nervous system—multiple sclerosis	0.000454	0.00279	CbGeAlD
Perphenazine—Hypotension—Azathioprine—multiple sclerosis	0.000451	0.00287	CcSEcCtD
Perphenazine—Triflupromazine—BCHE—multiple sclerosis	0.000451	0.214	CrCbGaD
Perphenazine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00045	0.00287	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—multiple sclerosis	0.00045	0.00287	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—multiple sclerosis	0.00045	0.00287	CcSEcCtD
Perphenazine—Cardiac arrest—Prednisone—multiple sclerosis	0.00045	0.00287	CcSEcCtD
Perphenazine—ADRA2A—central nervous system—multiple sclerosis	0.000446	0.00274	CbGeAlD
Perphenazine—Hypersensitivity—Cladribine—multiple sclerosis	0.000437	0.00279	CcSEcCtD
Perphenazine—ADRA2A—cerebellum—multiple sclerosis	0.000436	0.00268	CbGeAlD
Perphenazine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000428	0.00273	CcSEcCtD
Perphenazine—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000424	0.0027	CcSEcCtD
Perphenazine—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000424	0.0027	CcSEcCtD
Perphenazine—Bradycardia—Triamcinolone—multiple sclerosis	0.000422	0.00269	CcSEcCtD
Perphenazine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000421	0.00268	CcSEcCtD
Perphenazine—Pruritus—Cladribine—multiple sclerosis	0.00042	0.00268	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000419	0.00267	CcSEcCtD
Perphenazine—Muscular weakness—Prednisone—multiple sclerosis	0.000417	0.00266	CcSEcCtD
Perphenazine—Cough—Mitoxantrone—multiple sclerosis	0.000417	0.00266	CcSEcCtD
Perphenazine—Convulsion—Mitoxantrone—multiple sclerosis	0.000414	0.00264	CcSEcCtD
Perphenazine—Hypertension—Mitoxantrone—multiple sclerosis	0.000413	0.00263	CcSEcCtD
Perphenazine—CYP2C8—brain—multiple sclerosis	0.000411	0.00253	CbGeAlD
Perphenazine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000409	0.0026	CcSEcCtD
Perphenazine—Diarrhoea—Cladribine—multiple sclerosis	0.000406	0.00259	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—multiple sclerosis	0.000403	0.00257	CcSEcCtD
Perphenazine—HTR2A—nervous system—multiple sclerosis	0.000394	0.00242	CbGeAlD
Perphenazine—Confusional state—Mitoxantrone—multiple sclerosis	0.000393	0.00251	CcSEcCtD
Perphenazine—Dizziness—Cladribine—multiple sclerosis	0.000392	0.0025	CcSEcCtD
Perphenazine—Erythema—Prednisolone—multiple sclerosis	0.000392	0.0025	CcSEcCtD
Perphenazine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00039	0.00249	CcSEcCtD
Perphenazine—Infection—Mitoxantrone—multiple sclerosis	0.000387	0.00247	CcSEcCtD
Perphenazine—Shock—Mitoxantrone—multiple sclerosis	0.000384	0.00245	CcSEcCtD
Perphenazine—Bradycardia—Betamethasone—multiple sclerosis	0.000383	0.00244	CcSEcCtD
Perphenazine—Bradycardia—Dexamethasone—multiple sclerosis	0.000383	0.00244	CcSEcCtD
Perphenazine—Body temperature increased—Azathioprine—multiple sclerosis	0.000381	0.00243	CcSEcCtD
Perphenazine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000381	0.00243	CcSEcCtD
Perphenazine—HTR2A—central nervous system—multiple sclerosis	0.000379	0.00233	CbGeAlD
Perphenazine—Anorexia—Mitoxantrone—multiple sclerosis	0.000372	0.00237	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—multiple sclerosis	0.000372	0.00237	CcSEcCtD
Perphenazine—Headache—Cladribine—multiple sclerosis	0.000372	0.00237	CcSEcCtD
Perphenazine—HTR2A—cerebellum—multiple sclerosis	0.000371	0.00228	CbGeAlD
Perphenazine—Vision blurred—Prednisolone—multiple sclerosis	0.00037	0.00236	CcSEcCtD
Perphenazine—CYP2B6—brain—multiple sclerosis	0.000369	0.00227	CbGeAlD
Perphenazine—Hyperglycaemia—Prednisone—multiple sclerosis	0.000369	0.00235	CcSEcCtD
Perphenazine—CYP3A4—nervous system—multiple sclerosis	0.000365	0.00224	CbGeAlD
Perphenazine—Hypotension—Mitoxantrone—multiple sclerosis	0.000364	0.00232	CcSEcCtD
Perphenazine—Erythema—Triamcinolone—multiple sclerosis	0.000361	0.0023	CcSEcCtD
Perphenazine—HRH1—brain—multiple sclerosis	0.00036	0.00222	CbGeAlD
Perphenazine—Erythema—Methylprednisolone—multiple sclerosis	0.00036	0.00229	CcSEcCtD
Perphenazine—CYP2D6—nervous system—multiple sclerosis	0.000359	0.00221	CbGeAlD
Perphenazine—Angioedema—Prednisolone—multiple sclerosis	0.000358	0.00228	CcSEcCtD
Perphenazine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000355	0.00227	CcSEcCtD
Perphenazine—ADRA2A—brain—multiple sclerosis	0.000354	0.00218	CbGeAlD
Perphenazine—Syncope—Prednisolone—multiple sclerosis	0.000352	0.00224	CcSEcCtD
Perphenazine—CYP3A4—central nervous system—multiple sclerosis	0.000351	0.00216	CbGeAlD
Perphenazine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000348	0.00222	CcSEcCtD
Perphenazine—Somnolence—Mitoxantrone—multiple sclerosis	0.000347	0.00221	CcSEcCtD
Perphenazine—CYP2D6—central nervous system—multiple sclerosis	0.000345	0.00212	CbGeAlD
Perphenazine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000345	0.0022	CcSEcCtD
Perphenazine—Asthma—Methotrexate—multiple sclerosis	0.000342	0.00218	CcSEcCtD
Perphenazine—Convulsion—Prednisolone—multiple sclerosis	0.00034	0.00217	CcSEcCtD
Perphenazine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000339	0.00216	CcSEcCtD
Perphenazine—Hypertension—Prednisolone—multiple sclerosis	0.000339	0.00216	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—multiple sclerosis	0.000338	0.00216	CcSEcCtD
Perphenazine—CYP2D6—cerebellum—multiple sclerosis	0.000338	0.00208	CbGeAlD
Perphenazine—Pain—Mitoxantrone—multiple sclerosis	0.000334	0.00213	CcSEcCtD
Perphenazine—Constipation—Mitoxantrone—multiple sclerosis	0.000334	0.00213	CcSEcCtD
Perphenazine—Bradycardia—Prednisone—multiple sclerosis	0.000333	0.00212	CcSEcCtD
Perphenazine—Diarrhoea—Azathioprine—multiple sclerosis	0.00033	0.00211	CcSEcCtD
Perphenazine—Angioedema—Triamcinolone—multiple sclerosis	0.000329	0.0021	CcSEcCtD
Perphenazine—Angioedema—Methylprednisolone—multiple sclerosis	0.000329	0.0021	CcSEcCtD
Perphenazine—Erythema—Betamethasone—multiple sclerosis	0.000327	0.00209	CcSEcCtD
Perphenazine—Erythema—Dexamethasone—multiple sclerosis	0.000327	0.00209	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—multiple sclerosis	0.000325	0.00207	CcSEcCtD
Perphenazine—Syncope—Triamcinolone—multiple sclerosis	0.000323	0.00206	CcSEcCtD
Perphenazine—Syncope—Methylprednisolone—multiple sclerosis	0.000323	0.00206	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00032	0.00204	CcSEcCtD
Perphenazine—Dizziness—Azathioprine—multiple sclerosis	0.000319	0.00203	CcSEcCtD
Perphenazine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000317	0.00202	CcSEcCtD
Perphenazine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000316	0.00202	CcSEcCtD
Perphenazine—Shock—Prednisolone—multiple sclerosis	0.000315	0.00201	CcSEcCtD
Perphenazine—Cough—Triamcinolone—multiple sclerosis	0.000315	0.00201	CcSEcCtD
Perphenazine—Convulsion—Triamcinolone—multiple sclerosis	0.000312	0.00199	CcSEcCtD
Perphenazine—Tachycardia—Prednisolone—multiple sclerosis	0.000312	0.00199	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000312	0.00199	CcSEcCtD
Perphenazine—Convulsion—Methylprednisolone—multiple sclerosis	0.000312	0.00199	CcSEcCtD
Perphenazine—Hypertension—Triamcinolone—multiple sclerosis	0.000311	0.00198	CcSEcCtD
Perphenazine—Hypertension—Methylprednisolone—multiple sclerosis	0.000311	0.00198	CcSEcCtD
Perphenazine—Urticaria—Mitoxantrone—multiple sclerosis	0.00031	0.00198	CcSEcCtD
Perphenazine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000308	0.00197	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—multiple sclerosis	0.000305	0.00194	CcSEcCtD
Perphenazine—Headache—Azathioprine—multiple sclerosis	0.000302	0.00193	CcSEcCtD
Perphenazine—HTR2A—brain—multiple sclerosis	0.000301	0.00185	CbGeAlD
Perphenazine—Dry mouth—Triamcinolone—multiple sclerosis	0.0003	0.00191	CcSEcCtD
Perphenazine—Angioedema—Dexamethasone—multiple sclerosis	0.000299	0.00191	CcSEcCtD
Perphenazine—Angioedema—Betamethasone—multiple sclerosis	0.000299	0.00191	CcSEcCtD
Perphenazine—Confusional state—Methylprednisolone—multiple sclerosis	0.000296	0.00189	CcSEcCtD
Perphenazine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000294	0.00188	CcSEcCtD
Perphenazine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000294	0.00187	CcSEcCtD
Perphenazine—Syncope—Dexamethasone—multiple sclerosis	0.000293	0.00187	CcSEcCtD
Perphenazine—Syncope—Betamethasone—multiple sclerosis	0.000293	0.00187	CcSEcCtD
Perphenazine—Infection—Triamcinolone—multiple sclerosis	0.000292	0.00186	CcSEcCtD
Perphenazine—Infection—Methylprednisolone—multiple sclerosis	0.000292	0.00186	CcSEcCtD
Perphenazine—Shock—Triamcinolone—multiple sclerosis	0.00029	0.00185	CcSEcCtD
Perphenazine—Insomnia—Prednisolone—multiple sclerosis	0.000289	0.00185	CcSEcCtD
Perphenazine—Shock—Methylprednisolone—multiple sclerosis	0.000289	0.00184	CcSEcCtD
Perphenazine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000288	0.00183	CcSEcCtD
Perphenazine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000288	0.00183	CcSEcCtD
Perphenazine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000287	0.00183	CcSEcCtD
Perphenazine—Tachycardia—Triamcinolone—multiple sclerosis	0.000287	0.00183	CcSEcCtD
Perphenazine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000287	0.00183	CcSEcCtD
Perphenazine—Erythema—Prednisone—multiple sclerosis	0.000285	0.00182	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000284	0.00181	CcSEcCtD
Perphenazine—Convulsion—Dexamethasone—multiple sclerosis	0.000283	0.00181	CcSEcCtD
Perphenazine—Convulsion—Betamethasone—multiple sclerosis	0.000283	0.00181	CcSEcCtD
Perphenazine—Hypertension—Dexamethasone—multiple sclerosis	0.000282	0.0018	CcSEcCtD
Perphenazine—Hypertension—Betamethasone—multiple sclerosis	0.000282	0.0018	CcSEcCtD
Perphenazine—Hypotension—Methylprednisolone—multiple sclerosis	0.000274	0.00175	CcSEcCtD
Perphenazine—CYP2D6—brain—multiple sclerosis	0.000274	0.00169	CbGeAlD
Perphenazine—Pain—Prednisolone—multiple sclerosis	0.000274	0.00174	CcSEcCtD
Perphenazine—Vision blurred—Prednisone—multiple sclerosis	0.000269	0.00171	CcSEcCtD
Perphenazine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000267	0.0017	CcSEcCtD
Perphenazine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000267	0.0017	CcSEcCtD
Perphenazine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000267	0.0017	CcSEcCtD
Perphenazine—Insomnia—Triamcinolone—multiple sclerosis	0.000266	0.0017	CcSEcCtD
Perphenazine—Insomnia—Methylprednisolone—multiple sclerosis	0.000266	0.00169	CcSEcCtD
Perphenazine—Infection—Betamethasone—multiple sclerosis	0.000265	0.00169	CcSEcCtD
Perphenazine—Infection—Dexamethasone—multiple sclerosis	0.000265	0.00169	CcSEcCtD
Perphenazine—Shock—Dexamethasone—multiple sclerosis	0.000263	0.00168	CcSEcCtD
Perphenazine—Shock—Betamethasone—multiple sclerosis	0.000263	0.00168	CcSEcCtD
Perphenazine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000262	0.00167	CcSEcCtD
Perphenazine—Agitation—Prednisone—multiple sclerosis	0.000262	0.00167	CcSEcCtD
Perphenazine—Tachycardia—Betamethasone—multiple sclerosis	0.000261	0.00166	CcSEcCtD
Perphenazine—Tachycardia—Dexamethasone—multiple sclerosis	0.000261	0.00166	CcSEcCtD
Perphenazine—Angioedema—Prednisone—multiple sclerosis	0.00026	0.00166	CcSEcCtD
Perphenazine—Syncope—Prednisone—multiple sclerosis	0.000256	0.00163	CcSEcCtD
Perphenazine—Anorexia—Dexamethasone—multiple sclerosis	0.000255	0.00162	CcSEcCtD
Perphenazine—Anorexia—Betamethasone—multiple sclerosis	0.000255	0.00162	CcSEcCtD
Perphenazine—Urticaria—Prednisolone—multiple sclerosis	0.000254	0.00162	CcSEcCtD
Perphenazine—Pain—Triamcinolone—multiple sclerosis	0.000252	0.0016	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisone—multiple sclerosis	0.00025	0.0016	CcSEcCtD
Perphenazine—Hypotension—Betamethasone—multiple sclerosis	0.000249	0.00159	CcSEcCtD
Perphenazine—Hypotension—Dexamethasone—multiple sclerosis	0.000249	0.00159	CcSEcCtD
Perphenazine—Convulsion—Prednisone—multiple sclerosis	0.000247	0.00157	CcSEcCtD
Perphenazine—Hypertension—Prednisone—multiple sclerosis	0.000246	0.00157	CcSEcCtD
Perphenazine—Headache—Mitoxantrone—multiple sclerosis	0.000244	0.00156	CcSEcCtD
Perphenazine—Insomnia—Betamethasone—multiple sclerosis	0.000241	0.00154	CcSEcCtD
Perphenazine—Insomnia—Dexamethasone—multiple sclerosis	0.000241	0.00154	CcSEcCtD
Perphenazine—Erythema—Methotrexate—multiple sclerosis	0.000238	0.00152	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000236	0.0015	CcSEcCtD
Perphenazine—Urticaria—Triamcinolone—multiple sclerosis	0.000234	0.00149	CcSEcCtD
Perphenazine—Urticaria—Methylprednisolone—multiple sclerosis	0.000233	0.00149	CcSEcCtD
Perphenazine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000233	0.00148	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000233	0.00148	CcSEcCtD
Perphenazine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000232	0.00148	CcSEcCtD
Perphenazine—Decreased appetite—Betamethasone—multiple sclerosis	0.000232	0.00148	CcSEcCtD
Perphenazine—Infection—Prednisone—multiple sclerosis	0.000231	0.00147	CcSEcCtD
Perphenazine—Shock—Prednisone—multiple sclerosis	0.000229	0.00146	CcSEcCtD
Perphenazine—Pain—Dexamethasone—multiple sclerosis	0.000228	0.00146	CcSEcCtD
Perphenazine—Pain—Betamethasone—multiple sclerosis	0.000228	0.00146	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—multiple sclerosis	0.000227	0.00145	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—multiple sclerosis	0.000224	0.00143	CcSEcCtD
Perphenazine—Anorexia—Prednisone—multiple sclerosis	0.000222	0.00141	CcSEcCtD
Perphenazine—Chlorpromazine—BCHE—multiple sclerosis	0.000217	0.103	CrCbGaD
Perphenazine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000217	0.00138	CcSEcCtD
Perphenazine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000216	0.00138	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—multiple sclerosis	0.000213	0.00136	CcSEcCtD
Perphenazine—Urticaria—Dexamethasone—multiple sclerosis	0.000212	0.00135	CcSEcCtD
Perphenazine—Urticaria—Betamethasone—multiple sclerosis	0.000212	0.00135	CcSEcCtD
Perphenazine—Dizziness—Prednisolone—multiple sclerosis	0.000212	0.00135	CcSEcCtD
Perphenazine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000211	0.00135	CcSEcCtD
Perphenazine—Body temperature increased—Betamethasone—multiple sclerosis	0.000211	0.00135	CcSEcCtD
Perphenazine—Insomnia—Prednisone—multiple sclerosis	0.00021	0.00134	CcSEcCtD
Perphenazine—Pruritus—Triamcinolone—multiple sclerosis	0.000208	0.00133	CcSEcCtD
Perphenazine—Cough—Methotrexate—multiple sclerosis	0.000208	0.00132	CcSEcCtD
Perphenazine—Pruritus—Methylprednisolone—multiple sclerosis	0.000208	0.00132	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—multiple sclerosis	0.000206	0.00132	CcSEcCtD
Perphenazine—Decreased appetite—Prednisone—multiple sclerosis	0.000202	0.00129	CcSEcCtD
Perphenazine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000201	0.00128	CcSEcCtD
Perphenazine—Headache—Prednisolone—multiple sclerosis	0.0002	0.00128	CcSEcCtD
Perphenazine—Constipation—Prednisone—multiple sclerosis	0.000199	0.00127	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—multiple sclerosis	0.000196	0.00125	CcSEcCtD
Perphenazine—Dizziness—Triamcinolone—multiple sclerosis	0.000195	0.00124	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000194	0.00124	CcSEcCtD
Perphenazine—Dizziness—Methylprednisolone—multiple sclerosis	0.000194	0.00124	CcSEcCtD
Perphenazine—Infection—Methotrexate—multiple sclerosis	0.000193	0.00123	CcSEcCtD
Perphenazine—Pruritus—Dexamethasone—multiple sclerosis	0.000189	0.0012	CcSEcCtD
Perphenazine—Pruritus—Betamethasone—multiple sclerosis	0.000189	0.0012	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—multiple sclerosis	0.000185	0.00118	CcSEcCtD
Perphenazine—Urticaria—Prednisone—multiple sclerosis	0.000185	0.00118	CcSEcCtD
Perphenazine—Headache—Triamcinolone—multiple sclerosis	0.000184	0.00118	CcSEcCtD
Perphenazine—Headache—Methylprednisolone—multiple sclerosis	0.000184	0.00117	CcSEcCtD
Perphenazine—Body temperature increased—Prednisone—multiple sclerosis	0.000184	0.00117	CcSEcCtD
Perphenazine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000183	0.00116	CcSEcCtD
Perphenazine—Diarrhoea—Betamethasone—multiple sclerosis	0.000183	0.00116	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—multiple sclerosis	0.000182	0.00116	CcSEcCtD
Perphenazine—Dizziness—Betamethasone—multiple sclerosis	0.000177	0.00113	CcSEcCtD
Perphenazine—Dizziness—Dexamethasone—multiple sclerosis	0.000177	0.00113	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—multiple sclerosis	0.000176	0.00112	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—multiple sclerosis	0.000173	0.0011	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisone—multiple sclerosis	0.000171	0.00109	CcSEcCtD
Perphenazine—Acepromazine—ALB—multiple sclerosis	0.000171	0.0813	CrCbGaD
Perphenazine—Decreased appetite—Methotrexate—multiple sclerosis	0.000169	0.00108	CcSEcCtD
Perphenazine—Thioproperazine—ALB—multiple sclerosis	0.000167	0.0795	CrCbGaD
Perphenazine—Headache—Dexamethasone—multiple sclerosis	0.000167	0.00107	CcSEcCtD
Perphenazine—Headache—Betamethasone—multiple sclerosis	0.000167	0.00107	CcSEcCtD
Perphenazine—Pain—Methotrexate—multiple sclerosis	0.000166	0.00106	CcSEcCtD
Perphenazine—Thiothixene—ALB—multiple sclerosis	0.000165	0.0782	CrCbGaD
Perphenazine—Pipotiazine—ALB—multiple sclerosis	0.000165	0.0782	CrCbGaD
Perphenazine—Pruritus—Prednisone—multiple sclerosis	0.000165	0.00105	CcSEcCtD
Perphenazine—Diarrhoea—Prednisone—multiple sclerosis	0.000159	0.00101	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—multiple sclerosis	0.000154	0.000984	CcSEcCtD
Perphenazine—Dizziness—Prednisone—multiple sclerosis	0.000154	0.00098	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—multiple sclerosis	0.000154	0.00098	CcSEcCtD
Perphenazine—Headache—Prednisone—multiple sclerosis	0.000146	0.000929	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000143	0.000913	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—multiple sclerosis	0.000137	0.000877	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—multiple sclerosis	0.000133	0.000848	CcSEcCtD
Perphenazine—Clomipramine—ALB—multiple sclerosis	0.00013	0.0618	CrCbGaD
Perphenazine—Dizziness—Methotrexate—multiple sclerosis	0.000129	0.000819	CcSEcCtD
Perphenazine—Headache—Methotrexate—multiple sclerosis	0.000122	0.000776	CcSEcCtD
Perphenazine—Chlorpromazine—ALB—multiple sclerosis	8.92e-05	0.0424	CrCbGaD
Perphenazine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.16e-05	5.67e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.16e-05	5.67e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.15e-05	5.63e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.15e-05	5.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL5—multiple sclerosis	1.15e-05	5.59e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.13e-05	5.52e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.13e-05	5.52e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.13e-05	5.51e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.13e-05	5.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CD86—multiple sclerosis	1.13e-05	5.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CD86—multiple sclerosis	1.13e-05	5.49e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.13e-05	5.49e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.12e-05	5.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—APOE—multiple sclerosis	1.12e-05	5.48e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.12e-05	5.47e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.12e-05	5.46e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.12e-05	5.45e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.12e-05	5.45e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.12e-05	5.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—TYK2—multiple sclerosis	1.11e-05	5.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL5—multiple sclerosis	1.11e-05	5.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL5—multiple sclerosis	1.11e-05	5.41e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.11e-05	5.4e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	5.37e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.1e-05	5.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—APOE—multiple sclerosis	1.09e-05	5.3e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—APOE—multiple sclerosis	1.09e-05	5.3e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	5.25e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—TYK2—multiple sclerosis	1.07e-05	5.23e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—TYK2—multiple sclerosis	1.07e-05	5.23e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.07e-05	5.22e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.06e-05	5.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.06e-05	5.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SPP1—multiple sclerosis	1.06e-05	5.17e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.06e-05	5.16e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.04e-05	5.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IFNG—multiple sclerosis	1.04e-05	5.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCR5—multiple sclerosis	1.03e-05	5.03e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.03e-05	5.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SPP1—multiple sclerosis	1.03e-05	5.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SPP1—multiple sclerosis	1.03e-05	5.01e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TYK2—multiple sclerosis	1.02e-05	4.99e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	4.99e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	4.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	1.02e-05	4.96e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL2—multiple sclerosis	1.01e-05	4.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IFNG—multiple sclerosis	1e-05	4.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IFNG—multiple sclerosis	1e-05	4.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD4—multiple sclerosis	1e-05	4.89e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1e-05	4.87e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCR5—multiple sclerosis	9.99e-06	4.87e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCR5—multiple sclerosis	9.99e-06	4.87e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	9.95e-06	4.85e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—POMC—multiple sclerosis	9.92e-06	4.83e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TYK2—multiple sclerosis	9.91e-06	4.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TYK2—multiple sclerosis	9.91e-06	4.83e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	9.88e-06	4.82e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	9.85e-06	4.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	9.85e-06	4.8e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—APOE—multiple sclerosis	9.78e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL2—multiple sclerosis	9.77e-06	4.76e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL2—multiple sclerosis	9.77e-06	4.76e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	9.72e-06	4.74e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD4—multiple sclerosis	9.7e-06	4.73e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD4—multiple sclerosis	9.7e-06	4.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—POMC—multiple sclerosis	9.7e-06	4.73e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL2—multiple sclerosis	9.68e-06	4.72e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	9.67e-06	4.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—POMC—multiple sclerosis	9.65e-06	4.71e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—ALB—multiple sclerosis	9.65e-06	4.7e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	9.63e-06	4.69e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	9.52e-06	4.64e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	9.49e-06	4.63e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	9.46e-06	4.61e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	9.46e-06	4.61e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	9.45e-06	4.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—APOE—multiple sclerosis	9.4e-06	4.58e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—POMC—multiple sclerosis	9.34e-06	4.55e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—POMC—multiple sclerosis	9.34e-06	4.55e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—IL6—multiple sclerosis	9.32e-06	4.54e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	9.31e-06	4.54e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.31e-06	4.54e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	9.29e-06	4.53e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1B—multiple sclerosis	9.27e-06	4.52e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—CD4—multiple sclerosis	9.26e-06	4.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL2—multiple sclerosis	9.23e-06	4.5e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	9.16e-06	4.46e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—APOE—multiple sclerosis	9.09e-06	4.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—APOE—multiple sclerosis	9.09e-06	4.43e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—ALB—multiple sclerosis	9.04e-06	4.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IL6—multiple sclerosis	9.01e-06	4.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IL6—multiple sclerosis	9.01e-06	4.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1B—multiple sclerosis	8.96e-06	4.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1B—multiple sclerosis	8.96e-06	4.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CD4—multiple sclerosis	8.96e-06	4.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CD4—multiple sclerosis	8.96e-06	4.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL2—multiple sclerosis	8.93e-06	4.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL2—multiple sclerosis	8.93e-06	4.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	8.85e-06	4.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—ALB—multiple sclerosis	8.8e-06	4.29e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MYC—multiple sclerosis	8.79e-06	4.28e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	8.78e-06	4.28e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MYC—multiple sclerosis	8.78e-06	4.28e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	8.77e-06	4.27e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	8.76e-06	4.27e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—APOE—multiple sclerosis	8.73e-06	4.25e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.72e-06	4.25e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	8.66e-06	4.22e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	8.64e-06	4.21e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	8.62e-06	4.2e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	8.6e-06	4.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	8.59e-06	4.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—ALB—multiple sclerosis	8.51e-06	4.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—ALB—multiple sclerosis	8.51e-06	4.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CD80—multiple sclerosis	8.5e-06	4.14e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	8.47e-06	4.13e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—POMC—multiple sclerosis	8.4e-06	4.09e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	8.32e-06	4.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	8.28e-06	4.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	8.28e-06	4.03e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	8.24e-06	4.01e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CD80—multiple sclerosis	8.22e-06	4.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CD80—multiple sclerosis	8.22e-06	4.01e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	8.14e-06	3.97e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—POMC—multiple sclerosis	8.07e-06	3.93e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOE—multiple sclerosis	8.03e-06	3.91e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOE—multiple sclerosis	7.96e-06	3.88e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL2—multiple sclerosis	7.9e-06	3.85e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	7.88e-06	3.84e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	7.86e-06	3.83e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	7.84e-06	3.82e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—POMC—multiple sclerosis	7.81e-06	3.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—POMC—multiple sclerosis	7.81e-06	3.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—STAT3—multiple sclerosis	7.77e-06	3.79e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	7.73e-06	3.77e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ALB—multiple sclerosis	7.66e-06	3.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—multiple sclerosis	7.64e-06	3.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—multiple sclerosis	7.64e-06	3.72e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MYC—multiple sclerosis	7.57e-06	3.69e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	7.55e-06	3.68e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—STAT3—multiple sclerosis	7.51e-06	3.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—STAT3—multiple sclerosis	7.51e-06	3.66e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—POMC—multiple sclerosis	7.5e-06	3.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	7.48e-06	3.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.48e-06	3.64e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	7.4e-06	3.61e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	7.31e-06	3.56e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	7.27e-06	3.54e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	7.19e-06	3.5e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL2—multiple sclerosis	7.17e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TYK2—multiple sclerosis	7.17e-06	3.5e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—STAT3—multiple sclerosis	7.17e-06	3.5e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	7.15e-06	3.49e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	7.14e-06	3.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MAPK1—multiple sclerosis	7.06e-06	3.44e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	7e-06	3.41e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	6.97e-06	3.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TYK2—multiple sclerosis	6.94e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TYK2—multiple sclerosis	6.94e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—STAT3—multiple sclerosis	6.94e-06	3.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—STAT3—multiple sclerosis	6.94e-06	3.38e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	6.92e-06	3.37e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—POMC—multiple sclerosis	6.89e-06	3.36e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—POMC—multiple sclerosis	6.84e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—multiple sclerosis	6.83e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MAPK1—multiple sclerosis	6.83e-06	3.33e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MAPK1—multiple sclerosis	6.83e-06	3.33e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	6.8e-06	3.32e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—multiple sclerosis	6.8e-06	3.31e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	6.79e-06	3.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—multiple sclerosis	6.66e-06	3.25e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—multiple sclerosis	6.65e-06	3.24e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—multiple sclerosis	6.61e-06	3.22e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—multiple sclerosis	6.6e-06	3.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	6.54e-06	3.19e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MAPK1—multiple sclerosis	6.52e-06	3.18e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.51e-06	3.17e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.51e-06	3.17e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.49e-06	3.16e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	6.47e-06	3.15e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	6.46e-06	3.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—multiple sclerosis	6.45e-06	3.14e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—multiple sclerosis	6.45e-06	3.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—multiple sclerosis	6.43e-06	3.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—multiple sclerosis	6.43e-06	3.13e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.37e-06	3.1e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	6.33e-06	3.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK1—multiple sclerosis	6.31e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK1—multiple sclerosis	6.31e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—multiple sclerosis	6.29e-06	3.06e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—multiple sclerosis	6.23e-06	3.04e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	6.19e-06	3.02e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	6.15e-06	3e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	6.05e-06	2.95e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	6.04e-06	2.94e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—multiple sclerosis	5.97e-06	2.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—multiple sclerosis	5.94e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—POMC—multiple sclerosis	5.84e-06	2.85e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—multiple sclerosis	5.77e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—multiple sclerosis	5.77e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—multiple sclerosis	5.74e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—multiple sclerosis	5.74e-06	2.8e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	5.71e-06	2.78e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	5.7e-06	2.78e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—multiple sclerosis	5.69e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—multiple sclerosis	5.65e-06	2.75e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	5.62e-06	2.74e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—multiple sclerosis	5.61e-06	2.73e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	5.61e-06	2.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	5.6e-06	2.73e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	5.59e-06	2.72e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.5e-06	2.68e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.5e-06	2.68e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	5.49e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—multiple sclerosis	5.46e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—multiple sclerosis	5.46e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—multiple sclerosis	5.43e-06	2.64e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—multiple sclerosis	5.33e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—multiple sclerosis	5.25e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—multiple sclerosis	5.25e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.25e-06	2.56e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.11e-06	2.49e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.1e-06	2.49e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—multiple sclerosis	5.02e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—multiple sclerosis	5.01e-06	2.44e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5e-06	2.44e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.89e-06	2.38e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	4.87e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—multiple sclerosis	4.86e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—multiple sclerosis	4.86e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—multiple sclerosis	4.85e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—multiple sclerosis	4.85e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—multiple sclerosis	4.67e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	4.66e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	4.57e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—multiple sclerosis	4.51e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—multiple sclerosis	4.51e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.51e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	4.5e-06	2.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	4.5e-06	2.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	4.42e-06	2.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	4.42e-06	2.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.29e-06	2.09e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.23e-06	2.06e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—multiple sclerosis	4.22e-06	2.06e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.11e-06	2e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.84e-06	1.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—multiple sclerosis	3.51e-06	1.71e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—multiple sclerosis	3.39e-06	1.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—multiple sclerosis	3.39e-06	1.65e-05	CbGpPWpGaD
